Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Humer Franz Bdirector |
Sell | 11,200 @ $2.34 | $26,181 | 255,253 | 05/30/2024 | 06/03/2024 | |
Belldegrun Ariedirector |
Buy | 1,724,137 @ $2.90 | $5.00 M | 1,724,137 | 05/16/2024 | 05/20/2024 | |
Parker Geoffrey M.CHIEF FINANCIAL OFFICER |
Buy | 190 @ $3.60 | $683 | 819,590 | 01/30/2024 | 03/06/2024 | |
MESSEMER DEBORAH M.director |
Sell | 18,640 @ $2.70 | $50,317 | 62,456 | 12/18/2023 | 12/20/2023 | |
Mayo Stephendirector |
Sell | 10,000 @ $4.29 | $42,855 | 25,328 | 08/07/2023 | 08/09/2023 | |
Bhavnagri VeerGeneral Counsel |
Sell | 3,000 @ $6.85 | $20,550 | 577,677 | 02/13/2023 | 02/14/2023 | |
Bhavnagri Veerdirector: General Counsel |
Sell | 3,000 @ $7.04 | $21,120 | 580,677 | 01/17/2023 | 01/18/2023 | |
Bhavnagri Veerdirector: General Counsel |
Sell | 5,602 @ $7.53 | $42,186 | 583,677 | 12/15/2022 | 12/19/2022 | |
WITTE OWEN N.director: |
Sell | 5,000 @ $17.25 | $86,250 | 218,271 | 08/11/2022 | 08/15/2022 | |
WITTE OWEN N.director: |
Sell | 10,000 @ $16.50 | $165,000 | 223,271 | 08/11/2022 | 08/15/2022 | |
Amado RafaelEVP of R&D and CMO |
Sell | 2,000 @ $11.97 | $23,940 | 540,257 | 08/02/2022 | 08/02/2022 | |
Amado RafaelEVP of R&D and CMO |
Sell | 2,000 @ $11.44 | $22,880 | 542,257 | 07/05/2022 | 07/06/2022 |
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|
A. The list of insiders at Allogene Therapeutics, Inc. includes Mayo Stephen, MESSEMER DEBORAH M., Parker Geoffrey M., Belldegrun Arie, Humer Franz B.
A. Insiders have sold a total of 39,840 Allogene Therapeutics, Inc. shares in the last 12 months for a total of 119,353 sold.
A. The following insiders have sold Allogene Therapeutics, Inc. shares in the last 12 months: Mayo Stephen ($42,855), MESSEMER DEBORAH M. ($50,317), Humer Franz B ($26,181),
A. Insiders have purchased a total of 1.72 M Allogene Therapeutics, Inc. shares in the last 12 months for a total of 5.00 M sold.
A. The following insiders have purchased Allogene Therapeutics, Inc. shares in the last 12 months: Parker Geoffrey M. ($683), Belldegrun Arie ($5.00 M),